Form 4: Opko Health Sells Shares of GeneDx Holdings Corp.

Opko Health, a significant shareholder of GeneDx Holdings Corp., has sold a portion of its Class A Common Stock in two transactions.

Summary

• Opko Health, Inc., a major shareholder of GeneDx Holdings Corp., has reported the sale of Class A Common Stock.
• On August 12, 2024, Opko Health sold 59,787 shares at a weighted average price of $33.9507 per share.
• These shares were sold in multiple transactions with prices ranging from $33.16 to $34.90.
• On August 13, 2024, Opko Health sold an additional 24,987 shares at a weighted average price of $34.7582 per share.
• These shares were sold in multiple transactions with prices ranging from $34.50 to $35.9175.
• Following these transactions, Opko Health beneficially owns 2,786,796 shares of GeneDx Holdings Corp.
• The sales were executed by Steven D. Rubin, Exec. VP Administration, on behalf of Opko Health.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing stock sales, which doesn't inherently convey positive or negative sentiment. The impact on the stock price depends on market interpretation.

Risks

• The sale of shares by a major shareholder like Opko Health could potentially exert downward pressure on the stock price of GeneDx Holdings Corp.

Industry Context

Form 4 filings are standard practice when insiders or major shareholders trade company stock, providing transparency to the market.

Stakeholder Impact

• Shareholders may react to the news of Opko Health selling shares, potentially influencing the stock price.

Key Dates